So far, the mechanisms by which TATI is associated with tumour aggressiveness are unknown, but because no TATI receptor has been identified and TATI is a very specific trypsin inhibitor (Turpeinen et al, 1988), it is tempting to speculate that TATI exerts its effect through modulation of trypsin activity. The gene discussed is SPINK1; the disease is neoplasm.